Ajooni Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajooni Biotech Limited has filed its financial results for the quarter and half-year ended September 30, 2025 (Q2 FY2026) with the stock exchange. The filing itself is a routine compliance requirement under listing norms. No specific revenue, profit, or margin figures have been shared in this announcement. Investors will need to refer to the actual results document to assess the company's performance.
Neutral in isolation — this is a standard regulatory disclosure, not an event-driven update. The real impact depends on the numbers in the detailed results, which are not provided here.